Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (3): 439-444. doi: 10.19723/j.issn.1671-167X.2019.03.010

Previous Articles     Next Articles

Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study

Xiao-ying ZHANG1,2,*,Jia-yang JIN1,*,Jing HE1,Yu-zhou GAN1,Jia-li CHEN1,Xiao-zhen ZHAO1,Jia-jia LIU1,Xu-jie YOU1,Xue LI1,Jian-ping GUO1,Xiao-feng LI2,Jing LI1,Ru LI1△(),Zhan-guo LI1△()   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis(BZ0135), Beijing 100044, China
    2. Department of Rheumatology and Immunology,Second Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2019-03-15 Online:2019-06-18 Published:2019-06-26
  • Contact: Xiao-ying ZHANG,Jia-yang JIN E-mail:doctorliru123@163.com;li99@bjmu.edu.cn
  • Supported by:
    Supported by Tibet Autonomous Region National Science Foundation(XZ2017ZR-ZYZ02)and General Program of Shanxi Youth Science and Technology Research Foundation (2015021180)

RICH HTML

   

PDF (PC)

Abstract: Objective: To determine the associations between the family history of rheumatic diseases and clinical features in patients with rheumatoid arthritis (RA).Methods: In total, eight hundred and ninety patients with RA were enrolled. The demographic and clinical data were collected, including gender, age, height, body weight, age of disease onset, history of smoking and drinking, family history of rheumatic diseases, clinical and laboratory features, pain and global visual analogue scale (VAS), and multi-dimensional health assessment questionnaire (MDHAQ). Finally, 803 patients were completed the dataset and were included in the study. Results: In this cohort, the male/female ratio was 1 ∶3.5, and the age of onset was (45.09±14.50) years. A total of 123 (15.32%) patients were accompanied with family history of rheumatic diseases, including RA, spondyloarthritis, Sj?gren’s syndrome, systemic lupus erythematosus and systemic sclerosis. The percentages of first degree, second degree and both first and second degree relatives were 91 (73.98%), 22 (17.89%), and 10(8.13%) respectively. The most common disease was RA (70.73%), followed by other rheumatic diseases (21.95%), and RA combined with other rheumatic diseases (7.32%). The clinical and laboratory characteristics were compared between the patients with and without family history. The onset-age of the subjects was significantly different between those with and without family history of rheumatic diseases (39.97 ±13.68 vs. 46.01±14.46; P<0.01), which meant that the onset-age in patients with family history was 6.04 years earlier than that in patients without family history. The patients with family history had higher positive rate of rheumatoid factor (RF) compared with those without family history (78.48% vs. 66.67%, P<0.05). By adjusting with gender, body mass index (BMI), smoking and alcohol drinking, anti-cyclic citrullinated peptide (CCP) antibody and RF level, the age at disease onset in the patients with family history was 4.54 years earlier than that in the patients without family history (β=-4.54;95%CI:-8.70, -0.38;P<0.05). Further hierarchical regression analysis showed that, the age at onset of the RA patients with family history was 10.02 years earlier than that without family history among the smoking patients (β= -10.02;95%CI:-17.60, -2.43;P=0.01), while the age at onset of the RA patients with family history was 3.27 years earlier than that without family history among the never smoking patients (β=-3.27;95%CI:-8.37, 1.82;P=0.21).Conclusion: The family history of rheumatic diseases is a risk factor for early onset of RA, and may interact with smoking.

Key words: Rheumatoid arthritis, Family history, Age at onset, Smoking

CLC Number: 

  • R593.22

Table 1

Clinical and demographic features of all participants (n=803)"

Items Total (n=803) Family history of rheumatic disease
No (n=680) Yes (n=123) P
Female,n (%) 624 (77.71) 519 (76.32) 105 (85.37) 0.05
Han nationality,n (%) 715 (95.72) 614 (96.39) 101 (91.82) 0.03
Age/years, x?±s 55.53±13.52 56.20±13.39 51.86±13.69 <0.01
Age at RA onset/years, x?±s 45.09±14.50 46.01±14.46 39.97±13.68 <0.01
History of smoking, n (%) 222 (31.94) 185 (31.46) 37 (34.58) 0.53
History of drinking, n (%) 210 (27.23) 178 (27.30) 32 (26.89) 0.93
Disease duration/years, M (P25, P75) 7.00 (3.00,15.00) 7.00 (3.00,14.00) 10.00 (3.00, 16.00) 0.12
MDHAQ, M (P25, P75) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 0.32
Pain VAS, M (P25, P75) 3.0 (1.0, 6.0) 3.0 (1.0, 5.0) 3.0 (1.0, 6.0) 0.15
TJC,M (P25, P75) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 2.0 (0.0, 6.0) 0.73
SJC,M (P25, P75) 1.0 (0.0, 4.0) 1.0 (0.0, 4.0) 2.0 (0.0, 4.0) 0.37
DJC,M (P25, P75) 0.0 (0.0, 4.0) 0.0 (0.0, 4.0) 1.0 (0.0,7.0) 0.15
BMI/(kg/m2), x?±s 23.22±3.50 23.35±3.47 22.47±3.61 0.05
CRP/(mg/L),M (P25, P75) 4.68 (1.85, 11.72) 4.88 (2.00, 12.03) 3.40 (1.53, 10.54) 0.07
ESR/(mm/h), M (P25, P75) 19.0 (10.0, 37.8) 19.0 (11.0, 39.0) 17.0 (8.3, 29.5) 0.05
DAS28-CRP,M (P25, P75) 3.1 (2.2, 4.1) 3.0 (2.2, 4.1) 3.1 (2.1, 4.2) 0.96
DAS28-ESR,M (P25, P75) 3.6 (2.7, 4.7) 3.6 (2.7, 4.7) 3.3 (2.5, 4.5) 0.17
Anti-CCP positive, n (%) 509 (85.55) 441 (85.96) 68 (82.93) 0.47
RF-positive, n (%) 394 (68.28) 332 (66.67) 62 (78.48) <0.05

Table 2

Characteristics of family history of rheumatic diseases in RA patients (n=123)"

Relatives RA SpA SS SLE SSc RA with others Total, n (%)
First-degree relatives 70 6 5 5 1 4 91 (73.98)
Second-degree relatives 15 4 2 1 0 0 22 (17.89)
First- and second-degree relatives 2 1 1 1 0 5 10 (8.13)
Total, n (%) 87(70.73) 11 (8.94) 8 (6.51) 7 (5.69) 1(0.81) 9 (7.32) 123 (100.00)

Table 3

The effect of family history on age at onset in RA patients"

Items β(95%CI) P
Non-adjusted -6.04 (-8.79, -3.28) <0.01
Adjusted -4.54 (-8.70, -0.38) <0.05

Table 4

Stratification analysis of risk factors for age at onset of RA and interaction with family history"

Variable n β (95%CI) P (β) P (interaction)
Gender 0.20
Male 179 1.81(-8.81, 12.43) 0.74
Female 624 -6.78(-11.37, -2.20) <0.01
Nation 0.96
Han 715 -5.42(-9.71, -1.13) 0.01
Minority 32 -10.29(-39.73, 19.14) 0.51
Drinking 0.10
No 561 -7.32(-12.13, -2.51) <0.01
Yes 210 0.89(-7.88, 9.66) 0.84
Smoking 0.09
No 473 -3.27(-8.37, 1.82) 0.21
Yes 222 -10.02(-17.60, -2.43) 0.01
BMI/(kg/m2) 0.12
<24 337 -8.83(-14.66, -3.00) <0.01
24-28 145 -2.81(-9.87, 4.25) 0.44
>28 80 1.11(-10.52, 12.74) 0.85
RF 0.79
Negative 183 -5.10(-14.20, 4.00) 0.27
Positive 394 -5.78(-10.52, -1.03) <0.05
Anti-CCP 0.56
Negative 86 -8.92(-20.83, 2.98) 0.15
Positive 509 -4.75(-9.31, -0.19) <0.05
[1] Worthington J . Investigating the genetic basis of susceptibility to rheumatoid arthritis[J]. J Autoimmun, 2005,25(Suppl):16-20.
doi: 10.1016/j.jaut.2005.09.011
[2] Frisell T, Saevarsdottir S, Askling J . Family history of rheumatoid arthritis: an old concept with new developments[J]. Nat Rev Rheumatol, 2016,12(6):335-343.
doi: 10.1038/nrrheum.2016.52
[3] Lawrence, JS. Heberden Oration, 1969. Rheumatoid arthritis-nature ornurture[J] ? Ann Rheum Dis, 1970,29(4):357-379.
doi: 10.1136/ard.29.4.357
[4] Somers EC, Antonsen S, Pedersen L , et al. Parental history of lupus and rheumatoid arthritis and risk in offspring in a nationwide cohort study: does sex matter?[J]. Ann Rheum Dis, 2013,72(4):525-529.
doi: 10.1136/annrheumdis-2011-201165
[5] Laufer VA, Chen JY, Langefeld CD , et al. Integrative approaches to understanding the pathogenic role of genetic variation in rheumatic diseases[J]. Rheum Dis Clin North Am, 2017,43(3):449-466.
doi: 10.1016/j.rdc.2017.04.012
[6] Generali E, Ceribelli A, Stazi MA , et al. Lessons learned from twins in autoimmune and chronic inflammatory diseases[J]. J Autoimmun, 2017,83(9):51-61.
doi: 10.1016/j.jaut.2017.04.005
[7] Wordsworth P, Bell J . Polygenic susceptibility in rheumatoidarthritis[J]. Ann Rheum Dis, 1991,50(6), 343-346.
doi: 10.1136/ard.50.6.343
[8] Hemminki K, Li X, Sundquist J , et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions[J]. Arthritis Rheum, 2009,60(3):661-668.
doi: 10.1002/art.v60:3
[9] Okada Y, Wu D, Trynka G , et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery[J]. Nature, 2014,506(7488):376-381.
doi: 10.1038/nature12873
[10] Polderman, TJ, Benyamin B, de Leeuw CA, et al. Meta-analysis of the heritability of human traits based on fifty years of twin stu-dies[J]. Nat Genet, 2015,47(7):702-709.
doi: 10.1038/ng.3285
[11] Khoury MJ, Beaty TH, Liang KY . Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?[J]. Am J Epidemiol, 1988,127(3):674-683.
doi: 10.1093/oxfordjournals.aje.a114842
[12] Jiang X, Frisell T , AsklingJ, et al. To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?[J]. Arthritis Rheum, 2015,67(2):352-362.
doi: 10.1002/art.v67.2
[13] Frisell T, Holmqvist M, Källberg H , et al. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age[J]. Arthritis Rheum, 2013,65(11):2773-2782.
doi: 10.1002/art.38097
[14] Bang SY, Lee HS, Lee KW , et al. Interaction of HLA-DRB1*0901 and *0405 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope[J]. J Rheumatol, 2013,40(7):1054-1062.
doi: 10.3899/jrheum.121280
[15] Lee HS, Lee KW, Song GG , et al. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901[J]. Arthritis Rheum, 2004,50(11):3468-3475.
doi: 10.1002/(ISSN)1529-0131
[16] Chibnik LB, Keenan BT, Cui J , et al. Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset[J]. PLoS One, 2011,6(9):e24380.
doi: 10.1371/journal.pone.0024380
[17] Frisell T, Saevarsdottir S, Askling J . Does a family history of RA influence the clinical presentation and treatment response in RA?[J]. Ann Rheum Dis, 2016,75(6):1120-1125
doi: 10.1136/annrheumdis-2015-207670
[18] Kurko J, Besenyei T, Laki J , et al. Genetics of rheumatoid arthritis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2013,45(2):170-179.
doi: 10.1007/s12016-012-8346-7
[19] Diaz FJ, Rojas-Villarraga A, Salazar JC , et al. Anti-CCP antibo-dies are associated with early age at onset in patients with rheumatoid arthritis[J]. Joint Bone Spine, 2011,78(2):175-178.
doi: 10.1016/j.jbspin.2010.07.014
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[3] Yan DING, Lifang WANG, Chaoran LI, Zhemin LU, Lianjie SHI. Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1203-1207.
[4] Ju YANG, Jing XU, Juhua DAI, Lianjie SHI. Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 911-918.
[5] Lianghua FENG, Lirong HONG, Yujia CHEN, Xueming CAI. Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 919-925.
[6] Peiwen JIA, Ying YANG, Yaowei ZOU, Zhiming OUYANG, Jianzi LIN, Jianda MA, Kuimin YANG, Lie DAI. Clinical characteristics of overlapping syndromes of low muscle mass in patients with rheumatoid arthritis and their impact on physical function [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1009-1016.
[7] Doudou MA, Zhemin LU, Qian GUO, Sha ZHU, Jin GU, Yan DING, Lianjie SHI. Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1110-1114.
[8] Rui YAN, Dan KE, Yan ZHANG, Li LI, Huanran SU, Wei CHEN, Mingxia SUN, Xiaomin LIU, Liang LUO. Diagnostic significance of serum chemokine CXCL-10 and Krebs von den lungen-6 level in patients with rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 956-962.
[9] Liang ZHAO, Chenglong SHI, Ke MA, Jing ZHAO, Xiao WANG, Xiaoyan XING, Wanxing MO, Yirui LIAN, Chao GAO, Yuhui LI. Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 972-979.
[10] Yijun HAN, Xiaoli CHEN, Changhong LI, Jinxia ZHAO. Application status of methotrexate in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 994-1000.
[11] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[12] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[13] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd